Aceragen to Release Quarterly Earnings on Monday
| ACGNDelisted Stock | 0.75 0.23 23.47% |
About 62% of Aceragen's investor base is looking to short. The analysis of current outlook of investing in Aceragen suggests that many traders are alarmed regarding Aceragen's prospects. Aceragen's investing sentiment overview a quick insight into current market opportunities from investing in Aceragen. Many technical investors use Aceragen stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Aceragen |
Aceragen is scheduled to be announcing its earnings results on Monday, September 4th. Aceragen last issued its earnings results on Thursday, June 29th. The company reported EPS for the quarter. The firm had revenue of 2.47 million for the quarter. Aceragen Price Performance Shares
Read at thelincolnianonline.com
 |
Aceragen Fundamental Analysis
We analyze Aceragen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aceragen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aceragen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Z Score
Z Score Comparative Analysis
Aceragen is currently under evaluation in z score category among its peers. Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Aceragen Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aceragen stock to make a market-neutral strategy. Peer analysis of Aceragen could also be used in its relative valuation, which is a method of valuing Aceragen by comparing valuation metrics with similar companies.
Peers
Aceragen Related Equities
| QNRX | Quoin Pharmaceuticals | 28.12 | ||||
| ANEB | Anebulo Pharmaceuticals | 7.64 | ||||
| RNXT | RenovoRx | 5.83 | ||||
| SABS | SAB Biotherapeutics | 4.27 | ||||
| ACRV | Acrivon Therapeutics, | 0.13 | ||||
| COCP | Cocrystal Pharma | 2.44 | ||||
| SNGX | Soligenix | 2.71 | ||||
| ARMP | Armata Pharmaceuticals | 2.73 | ||||
| ATXI | Avenue Therapeutics | 3.61 | ||||
| BPTH | Bio Path | 4.05 | ||||
| ADXN | Addex Therapeutics | 4.67 | ||||
| AKTX | Akari Therapeutics | 5.15 | ||||
| IBIO | Ibio | 7.14 | ||||
| PCSA | Processa Pharmaceuticals | 7.76 | ||||
| TPST | Tempest Therapeutics | 8.42 | ||||
| ACXP | Acurx Pharmaceuticals | 18.75 | ||||
| SNTI | Senti Biosciences | 28.60 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Aceragen Stock
If you are still planning to invest in Aceragen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aceragen's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |